BR112015022739A2 - processo de fabricação para uma forma de dosagem efervescente - Google Patents

processo de fabricação para uma forma de dosagem efervescente

Info

Publication number
BR112015022739A2
BR112015022739A2 BR112015022739A BR112015022739A BR112015022739A2 BR 112015022739 A2 BR112015022739 A2 BR 112015022739A2 BR 112015022739 A BR112015022739 A BR 112015022739A BR 112015022739 A BR112015022739 A BR 112015022739A BR 112015022739 A2 BR112015022739 A2 BR 112015022739A2
Authority
BR
Brazil
Prior art keywords
dosage form
manufacturing process
effervescent dosage
methods
effervescent
Prior art date
Application number
BR112015022739A
Other languages
English (en)
Inventor
Bartley Tammy
Original Assignee
Mylan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Inc filed Critical Mylan Inc
Publication of BR112015022739A2 publication Critical patent/BR112015022739A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)

Abstract

resumo processo de fabricação para uma forma de dosagem efervescente os métodos de fabricação de formas de dosagem efervescente. métodos de fabrico de um comprimido efervescente com um processo de compressão direta a seco são divulgados. os métodos não resultam na colagem da mistura a ser transformada em comprimidos aos punções durante a produção.
BR112015022739A 2013-03-15 2014-03-15 processo de fabricação para uma forma de dosagem efervescente BR112015022739A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361790213P 2013-03-15 2013-03-15
PCT/US2014/030020 WO2014145285A1 (en) 2013-03-15 2014-03-15 Manufacturing process for effervescent dosage forms

Publications (1)

Publication Number Publication Date
BR112015022739A2 true BR112015022739A2 (pt) 2017-07-18

Family

ID=51527885

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022739A BR112015022739A2 (pt) 2013-03-15 2014-03-15 processo de fabricação para uma forma de dosagem efervescente

Country Status (7)

Country Link
US (1) US20140271492A1 (pt)
EP (1) EP2983719A4 (pt)
CN (1) CN105407925A (pt)
AU (1) AU2014233139A1 (pt)
BR (1) BR112015022739A2 (pt)
CA (1) CA2906987A1 (pt)
WO (1) WO2014145285A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015175982A1 (en) * 2014-05-16 2015-11-19 Vivus, Inc. Orally administrable formulations for the controlled release of a pharmacologically active agent
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
CN106387915B (zh) * 2016-11-23 2021-12-28 宁夏五行科技有限公司 杞咖益元泡腾片及其制备工艺和应用
CN107434753A (zh) * 2017-07-26 2017-12-05 南京大学 5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法
EP3637188A1 (en) * 2018-10-08 2020-04-15 Agfa Nv An effervescent developer precursor for processing a lithographic printing plate precursor
MX2022004643A (es) * 2019-10-17 2022-07-27 Isp Investments Llc Una composición de excipiente coprocesado efervescente estable y un proceso de preparación de la misma.
CN113564609A (zh) * 2021-06-09 2021-10-29 湖北中油优艺环保科技集团有限公司 一种焚烧系统高效除垢剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH667374A5 (fr) * 1986-02-11 1988-10-14 Dridrinks Nv Composition pulverulente hydrosoluble non hygroscopique destinee a la preparation de boissons a degagement gazeux prolonge et procede pour sa preparation.
EP0939624B1 (en) * 1996-05-17 2003-12-17 Merck & Co., Inc. Effervescent bisphosphonate formulation
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2005065319A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
CN1569133A (zh) * 2004-04-29 2005-01-26 浙江天一堂集团有限公司 双黄连泡腾片及其制备方法
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
GB2480042B (en) * 2009-02-24 2014-03-12 Ritter Pharmaceuticals Inc Solid oral unit-dosage prebiotic forms and methods of use
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
US20110281008A1 (en) * 2010-04-13 2011-11-17 Amerilab Technologies, Inc. Effervescent tablet with improved dissolution time and method of using the same
CN102488681B (zh) * 2011-12-21 2013-03-13 西南大学 布洛芬苯海拉明口腔崩解片及其制备方法
CN103432161B (zh) * 2013-08-13 2015-11-25 深圳市麦金利实业有限公司 多种维生素矿物质泡腾片及其制备方法

Also Published As

Publication number Publication date
CN105407925A (zh) 2016-03-16
AU2014233139A1 (en) 2016-01-21
WO2014145285A1 (en) 2014-09-18
EP2983719A1 (en) 2016-02-17
US20140271492A1 (en) 2014-09-18
CA2906987A1 (en) 2014-09-18
EP2983719A4 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
BR112015022739A2 (pt) processo de fabricação para uma forma de dosagem efervescente
CU20150095A7 (es) Pirimidinas fusionadas sustituidas con trifluorometilo
UY36771A (es) Moduladores cot y métodos de uso de los mismos
UY35508A (es) Derivados de oxopiridina sustituidos
SG11201506643VA (en) Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
SG11201506293QA (en) Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
AR091733A1 (es) Proceso para producir minerales que contienen carbonato de calcio de superficie modificada
CL2017001632A1 (es) Manufactura de proteína.
SG11201506098WA (en) Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
MX2018004831A (es) Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina.
EP2970062A4 (en) PROCESS FOR DELETING THE FORMATION OF 3,3,3-TRIFLUOROPROPYNE IN THE PRODUCTION OF FLUOROCARBON COMPOUNDS
CR20160136A (es) Compuestos heterocíclicos
DOP2015000187A (es) Proceso de fabricación de vortioxetina
AU347999S (en) Snack product
BR112015032357A2 (pt) processos para a produção de cacau natural marrom vermelho escuro e escuro
CL2018002149A1 (es) Proceso.
GT201500340A (es) Una composición, proceso y un kit para el procesamiento del azúcar
ZA201804457B (en) Process to reduce the overall energy consumption in the production of nanocellulose
BR112014019526B8 (pt) Forma de dosagem de liberação rápida e seu método de produção
BR112016010964A2 (pt) Processo para desidratar uma mistura que contém etanol e n-propanol
AR096501A1 (es) Método para la fabricación de envases de vidrio para uso farmacéutico
TWD160263S (zh) 具有支座的平板電腦
GB201319635D0 (en) Method to reduce the occurrence of air bubbles in contact lens manufacture
AU349293S (en) Truss for a building
RU2014130112A (ru) Лекарственное средство церебропротекторного действия

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/38 (2006.01), A61K 47/30 (2006.01)

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]